The U.S. Department of Veterans Affairs (VA) has awarded a Federal Supply Schedule (FSS) contract to Telix Pharmaceuticals US Inc., a global biopharmaceutical company, to provide radiopharmaceutical products for nuclear medicine and medical imaging services. The $225,000 multiple-award contract has an ultimate completion date of August 2027 and falls under FSS 65 I B for drugs, pharmaceuticals, and related products. Under this FSS contract, the VA has issued several firm fixed-price delivery orders to Telix Pharmaceuticals for the supply of radiopharmaceuticals such as Illuccix for prostate cancer imaging and Gozetotide for other nuclear medicine procedures. The delivery orders range from $165,000 to $479,500 and have ultimate completion dates through 2025. Additionally, the VA has awarded Telix Pharmaceuticals two Blanket Purchase Agreements (BPAs) valued at $17.5 million and $4.5 million to facilitate the procurement of Illuccix and other radiopharmaceuticals through 2028. These contract vehicles allow the VA to efficiently acquire Telix's products to support its healthcare system serving veterans across the country.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| P00008 | Supplemental Agreement for work within scope | $0 | 12/30/24 | |
| P00007 | Supplemental Agreement for work within scope | $0 | 12/2/24 | |
| P00006 | Supplemental Agreement for work within scope | $0 | 9/11/24 | |
| P00005 | Supplemental Agreement for work within scope | $0 | 12/28/23 | |
| P00004 | Supplemental Agreement for work within scope | $0 | 12/21/23 |
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Last Date To Order (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
36F79722D0197-36C24924A0002 | Telix Pharmaceuticals US Inc. | $4.5m | 10/1/23 | 9/30/28 | 9/23/24 | |
36F79722D0197-36E79722A0025 | Telix Pharmaceuticals US Inc. | $17.5m | 8/30/22 | 8/29/25 | 12/4/24 |
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order 36F79722D0197-36C25725N0084 | Telix Pharmaceuticals US Inc. | $165.0k | 10/25/24 | 10/24/25 | 10/16/24 | |
Delivery Order 36F79722D0197-36C26225F0243 | Telix Pharmaceuticals US Inc. | $316.8k | 2/11/25 | 2/11/26 | 1/28/25 | |
Delivery Order 36F79722D0197-36C26224F0036 | Telix Pharmaceuticals US Inc. | $334.3k | 11/1/23 | 10/31/24 | 1/24/25 | |
Delivery Order 36F79722D0197-36C26223F0064 | Telix Pharmaceuticals US Inc. | $479.5k | 11/7/22 | 11/6/23 | 2/2/24 | |
BPA Call 36C24924A0002-36C24924N0048 | Telix Pharmaceuticals US Inc. | $774.7k | 10/1/23 | 9/30/24 | 1/23/25 |